LAMU is developing a universal industrial process to reduce sugar in natural beverages, and to provide food and beverage manufacturers the freedom to choose the amount of sugar in their products.

The company specializes in R&D and manufacturing of technologies and respiratory protection for the public and the medical community.

Specializing in physiological algorithms and artificial intelligence (AI), and their incorporation in the fields of medicine, sports, insurance and sport support. The company has a cloud marketplace for its operations. It is currently in the advanced stages of launching clinical trials with the leading hospitals in Israel using its digital sensor-based system in the respiratory rehabilitation process of COVID-19 and COPD (chronic obstructive pulmonary disease) patients. The implementation of the system developed by Biogradient will decrease hospitalization days by approximately 40%, thus freeing hospital beds and resources and their related expenses.

Ranked among the five largest producers of eggs in Israel, the company focuses on vertical integration, providing quality control at all stages of production and ensuring optimal resource usage. This ranges from the breeding stage of the layers to the grading and sorting of the eggs and the distribution of edible eggs based on trade agreements. The company's sorting plant is equipped with an exclusive technology that enables the detection of fractures in the eggshell, reducing the pollution of the chain of supply and the incurring returns and losses, thus creating a distinct market advantage to both the company and its clients.

Se-cure is a research-driven Israeli Pharmaceutical company, which has developed a proprietary platform for the discovery, development and scaling of therapies from botanical origin. Founded in 1997, Se-cure processes natural complex of biochemical compounds as found in the original plant, as a basis for designing therapies which selectively target specific tissues, while leaving other tissues intact.